Accuray Inc (ARAY)
1.93
+0.04
(+2.12%)
USD |
NASDAQ |
Nov 22, 16:00
1.93
0.00 (0.00%)
Pre-Market: 20:00
Accuray Free Cash Flow: -14.24M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -14.24M |
June 30, 2024 | -15.50M |
March 31, 2024 | -24.08M |
December 31, 2023 | 7.607M |
September 30, 2023 | -5.599M |
June 30, 2023 | 2.858M |
March 31, 2023 | -4.028M |
December 31, 2022 | -49.64M |
September 30, 2022 | 1.713M |
June 30, 2022 | -7.117M |
March 31, 2022 | 4.225M |
December 31, 2021 | 42.70M |
September 30, 2021 | 29.58M |
June 30, 2021 | 36.19M |
March 31, 2021 | 48.92M |
December 31, 2020 | 20.75M |
September 30, 2020 | 17.25M |
June 30, 2020 | -5.197M |
March 31, 2020 | -15.21M |
December 31, 2019 | -10.84M |
September 30, 2019 | -40.42M |
June 30, 2019 | -33.95M |
March 31, 2019 | -16.09M |
December 31, 2018 | -6.377M |
September 30, 2018 | 6.253M |
Date | Value |
---|---|
June 30, 2018 | 11.72M |
March 31, 2018 | 7.241M |
December 31, 2017 | -7.303M |
September 30, 2017 | -11.64M |
June 30, 2017 | -5.744M |
March 31, 2017 | -9.488M |
December 31, 2016 | -7.454M |
September 30, 2016 | 4.085M |
June 30, 2016 | 22.86M |
March 31, 2016 | -1.117M |
December 31, 2015 | 8.456M |
September 30, 2015 | 3.268M |
June 30, 2015 | -24.85M |
March 31, 2015 | -21.33M |
December 31, 2014 | -8.931M |
September 30, 2014 | -14.54M |
June 30, 2014 | -11.58M |
March 31, 2014 | -16.52M |
December 31, 2013 | -50.09M |
September 30, 2013 | -77.28M |
June 30, 2013 | -81.54M |
March 31, 2013 | -82.34M |
December 31, 2012 | -57.98M |
September 30, 2012 | -17.45M |
June 30, 2012 | -49.05M |
Free Cash Flow Range, Past 5 Years
-49.64M
Minimum
Dec 2022
48.92M
Maximum
Mar 2021
3.017M
Average
-1.158M
Median
Free Cash Flow Benchmarks
Baxter International Inc | 391.00M |
Boston Scientific Corp | 1.892B |
Perspective Therapeutics Inc | -40.58M |
Xtant Medical Holdings Inc | -17.28M |
Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -7.294M |
Cash from Investing (Quarterly) | -1.12M |
Cash from Financing (Quarterly) | -2.173M |
Free Cash Flow Per Share (Quarterly) | -0.084 |
Free Cash Flow to Equity (Quarterly) | -6.498M |
Free Cash Flow to Firm (Quarterly) | -4.904M |
Free Cash Flow Yield | -7.44% |